Adjust Font Increase Font Decrease Font

The Biopharmaceutical Sector’s Impact on the Economy of Missouri

This fact sheet presents an analysis of the impact of the biopharmaceutical sector on the economy of Missouri (MO) in 2008, including data on employment, economic output, and research and development activity. The biopharmaceutical sector’s economic impact includes not only the direct impact of its companies, but also the ripple effects that the sector has throughout the rest of the economy. These ripple effects include both the indirect impact, the economic value of the goods or services used to support biopharmaceutical companies, and the induced impact, the value of the economic activity supported by the spending of the direct and indirect employees of the biopharmaceutical sector.

Download Fact Sheet (PDF)

 

 

 

 

 

 

 

 

 

 

 

 

Additional Information on the Biopharmaceutical Sector’s Impact in Missouri:
 
PhRMA commissioned Battelle to conduct this study to examine the extent to which state governments are targeting the industry for economic growth and development:
 
  • Missouri has a sizable and rapidly growing biopharmaceutical industry that supported more than 65,000 jobs and contributed $11.1 billion to the state economy in 2006, including direct, indirect and induced impacts
  • In 2007, Missouri committed $355 million for facility and infrastructure improvements at Missouri’s colleges and universities through its Lewis and Clark Discovery Initiative
  • Missouri’s Life Sciences Research Trust Fund provides funding, in cooperation with other governmental and not-for-profit private entities, to enhance the state’s ability to perform research that will better serve the health and welfare of its residents

*Battelle state fact sheets use the latest data available at the time of publication. This may predate the data from the Archstone reports, which use 2008 data.